MSC Receptor Ratio Screening for Chondrogenic Potential
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The variability in chondrogenic potential among human mesenchymal stromal cells (hMSCs) from different donors complicates their use for cartilage regeneration, as current methods for identifying suitable donors are inefficient and require extensive culturing and histological characterization.
Innovation Solution
The ratio of TGFβR1 to TGFβR2 receptors in hMSCs serves as an indicator for chondrogenic potential, and manipulating these receptors through methods like gene silencing or overexpression can enhance or identify cells with increased differentiation capacity in the chondrocytic lineage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple rounds of donor cell culturing and histological characterization are performed to identify good donors, then the accuracy of identifying high chondrogenic potential cells is improved, but the time consumption and process complexity increase significantly
Solution Approach 1:
The patent applies preliminary action by measuring TGFβR1 and TGFβR2 receptor expression levels in donor cells before initiating chondrogenic differentiation culturing. This preliminary measurement of receptor ratios allows identification of high-potential donors prior to time-consuming differentiation protocols, thereby reducing overall time consumption while maintaining identification accuracy.
Solution Approach 2:
The patent replaces the mechanical system of extensive cell culturing and histological characterization with a molecular biology-based detection method. By using qPCR or flow cytometry to measure TGFβR1 and TGFβR2 receptor expression levels, the invention substitutes lengthy phenotypic assessment with rapid genotypic analysis, significantly reducing time and complexity.
2Reliability
If extensive cell culturing and histological characterization are performed to determine chondrogenic potential, then the reliability of donor selection is improved, but the device complexity and operational difficulty increase
Solution Approach 1:
The patent replaces complex mechanical procedures of cell culturing and histological processing with molecular detection techniques. By measuring TGFβR1 and TGFβR2 mRNA or protein levels using qPCR or flow cytometry, the invention achieves reliable donor selection through simplified analytical procedures that require standard molecular biology equipment rather than extensive tissue processing infrastructure.
Solution Approach 2:
The patent changes the measurement parameter from phenotypic outcomes (histological characterization of differentiated cartilage) to molecular markers (TGFβR1 and TGFβR2 receptor expression levels). This parameter change enables reliable donor selection through direct measurement of predictive molecular signatures, avoiding the need for complex differentiation and histological analysis procedures.
3Reliability
If only a subset of donors with high chondrogenic potential is used, then the quality of cartilage regeneration is improved, but the availability of suitable cell sources is reduced
Solution Approach 1:
The patent applies preliminary action by assessing TGFβR1 and TGFβR2 receptor ratios in donor cells before selection. This preliminary molecular characterization enables identification of high-potential donors from the broader donor pool, allowing expansion of the available cell sources while maintaining quality standards through objective molecular criteria rather than relying on limited historical data or trial-and-error approaches.
Solution Approach 2:
The patent changes the selection parameter from empirical outcomes (observing differentiation results after lengthy culturing) to predictive molecular markers (TGFβR1/TGFβR2 receptor ratios). This parameter change enables more donors to be screened and identified as suitable, expanding the available cell sources while ensuring quality through the reliable molecular signature that predicts chondrogenic potential.
Data Source
AI summary
A method of increasing the chondrogenic potential mediated by TGFβ of a mesenchymal stromal cell (MSC) or a population of mesenchymal stromal cells (MSCs), comprising the step of increasing the amount of TGFβR1, and/or decreasing the amount of TGFβR2, and/or decreasing the amount of and/or ACVRL1 of the MSC or a population of mesenchymal stromal cells (MSCs).